Skip to main content
Top
Published in: Arthritis Research & Therapy 6/2007

Open Access 01-12-2006 | Research article

Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population

Authors: Sang-Hoon Lee, Yeon-Ah Lee, Doo-Hyun Woo, Ran Song, Eun-Kyung Park, Mi-Hyun Ryu, Young-Hoon Kim, Kyoung-Soo Kim, Seung-Jae Hong, Myung Chul Yoo, Hyung-In Yang

Published in: Arthritis Research & Therapy | Issue 6/2007

Login to get access

Abstract

The PD-1 (programmed death 1) molecule is a negative regulator of T cells. PDCD1 (programmed cell death 1) has been reported to have a genetic association in systemic lupus erythematosus and rheumatoid arthritis in Caucasians. However, there are no reports on the association between this gene and ankylosing spondylitis (AS). The present study investigated the association of the PD-1 polymorphisms and the haplotypes with AS in a Korean population sample. In a case-control association study, two single-nucleotide polymorphisms, PD-1.5 C/T and PD-1.9 T/C, were genotyped in 95 AS patients and 130 healthy controls. The T allele of the PD-1.9 polymorphism was more frequent in the Korean male population with AS than in the Korean male controls (21.0% versus 6.9%, odds ratio 1.89, 95% confidence interval 1.483 to 2.408). The frequency of the CT haplotype (PD-1.5 C/T and PD-1.9 T/C) was higher in the AS patients (19%) than the controls (5.4%) (odds ratio 1.83, 95% confidence interval 1.559 to 2.521). The PD-1 polymorphism was demonstrated in Korean AS patients. The results suggest a genetic association between the PD-1 polymorphism and susceptibility to AS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Johnsen K, Gran JT, Dale K, Husby G: The prevalence of ankylosing spondylitis among Norwegian Samis (Lapps). J Rheumatol. 1992, 19: 1591-1594.PubMed Johnsen K, Gran JT, Dale K, Husby G: The prevalence of ankylosing spondylitis among Norwegian Samis (Lapps). J Rheumatol. 1992, 19: 1591-1594.PubMed
2.
go back to reference Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, distler A, Sipper J: Prevalence of spondylarthropathies in HLA B27-positive and -negative blood donors. Arthritis Rheum. 1998, 41: 58-67. 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G.CrossRefPubMed Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, distler A, Sipper J: Prevalence of spondylarthropathies in HLA B27-positive and -negative blood donors. Arthritis Rheum. 1998, 41: 58-67. 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G.CrossRefPubMed
3.
go back to reference Sieper J, Rudwaleit M: How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?. Ann Rheum Dis. 2005, 64 (Suppl 4): 61-64. Sieper J, Rudwaleit M: How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?. Ann Rheum Dis. 2005, 64 (Suppl 4): 61-64.
4.
go back to reference van der Linden SM, Valkenburg HA, de Jongh BM, Cats A: The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum. 1984, 27: 241-249.CrossRefPubMed van der Linden SM, Valkenburg HA, de Jongh BM, Cats A: The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum. 1984, 27: 241-249.CrossRefPubMed
5.
go back to reference Brown MA, Laval SH, Brophy S, Calin A: Recurrence risk modeling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000, 59: 883-886. 10.1136/ard.59.11.883.PubMedCentralCrossRefPubMed Brown MA, Laval SH, Brophy S, Calin A: Recurrence risk modeling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000, 59: 883-886. 10.1136/ard.59.11.883.PubMedCentralCrossRefPubMed
6.
go back to reference Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, Taylor A, Calin A, Wordsworth P: Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997, 40: 1823-1828.CrossRefPubMed Brown MA, Kennedy LG, MacGregor AJ, Darke C, Duncan E, Shatford JL, Taylor A, Calin A, Wordsworth P: Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997, 40: 1823-1828.CrossRefPubMed
7.
go back to reference Allen RL, Raine T, Haude A, Trowsdale J, Wilson MJ: Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol. 2001, 167: 5543-5547.CrossRefPubMed Allen RL, Raine T, Haude A, Trowsdale J, Wilson MJ: Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol. 2001, 167: 5543-5547.CrossRefPubMed
8.
go back to reference Sanghera DK, Manzi S, Bontempo F, Nestlerode C, Kamboh MI: Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphopholipid antibodies. Hum Genet. 2004, 115: 393-398. 10.1007/s00439-004-1172-0.CrossRefPubMed Sanghera DK, Manzi S, Bontempo F, Nestlerode C, Kamboh MI: Role of an intronic polymorphism in the PDCD1 gene with the risk of sporadic systemic lupus erythematosus and the occurrence of antiphopholipid antibodies. Hum Genet. 2004, 115: 393-398. 10.1007/s00439-004-1172-0.CrossRefPubMed
9.
go back to reference Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F, Liz M, Martin J, Ordi J, Vicario JL, et al: Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum. 2004, 50: 2590-2597. 10.1002/art.20436.CrossRefPubMed Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F, Liz M, Martin J, Ordi J, Vicario JL, et al: Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum. 2004, 50: 2590-2597. 10.1002/art.20436.CrossRefPubMed
10.
go back to reference Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristiansdottir H, Grondal G, et al: A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet. 2002, 32: 666-669. 10.1038/ng1020.CrossRefPubMed Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristiansdottir H, Grondal G, et al: A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet. 2002, 32: 666-669. 10.1038/ng1020.CrossRefPubMed
11.
go back to reference Prokunina L, Gunnarsson I, Sturfelt G, Truedsson L, Seligman VA, Olson JL, Seldin MF, Criswell LA, Alarcon-Riquelme ME, et al: The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum. 2004, 50: 327-328. 10.1002/art.11442.CrossRefPubMed Prokunina L, Gunnarsson I, Sturfelt G, Truedsson L, Seligman VA, Olson JL, Seldin MF, Criswell LA, Alarcon-Riquelme ME, et al: The systemic lupus erythematosus-associated PDCD1 polymorphism PD1.3A in lupus nephritis. Arthritis Rheum. 2004, 50: 327-328. 10.1002/art.11442.CrossRefPubMed
12.
go back to reference Prokunina L, Pdyukov L, Bennet A, de Faire U, Wiman B, Prince J, Alfredsson L, Klareskog L, Alarcon-Riquelme M: Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum. 2004, 50: 1770-1773. 10.1002/art.20280.CrossRefPubMed Prokunina L, Pdyukov L, Bennet A, de Faire U, Wiman B, Prince J, Alfredsson L, Klareskog L, Alarcon-Riquelme M: Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum. 2004, 50: 1770-1773. 10.1002/art.20280.CrossRefPubMed
13.
go back to reference Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N, et al: Autoimmune dilated cardiomyopathy in PD-1 receptor deficient mice. Science. 2001, 291: 319-322. 10.1126/science.291.5502.319.CrossRefPubMed Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N, et al: Autoimmune dilated cardiomyopathy in PD-1 receptor deficient mice. Science. 2001, 291: 319-322. 10.1126/science.291.5502.319.CrossRefPubMed
14.
go back to reference Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, et al: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000, 192: 1027-1034. 10.1084/jem.192.7.1027.PubMedCentralCrossRefPubMed Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, et al: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000, 192: 1027-1034. 10.1084/jem.192.7.1027.PubMedCentralCrossRefPubMed
15.
go back to reference Nishimura H, Honjo T: PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 2001, 22: 265-268. 10.1016/S1471-4906(01)01888-9.CrossRefPubMed Nishimura H, Honjo T: PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 2001, 22: 265-268. 10.1016/S1471-4906(01)01888-9.CrossRefPubMed
16.
go back to reference Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, et al: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol. 2001, 2: 261-268. 10.1038/85330.CrossRefPubMed Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, et al: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol. 2001, 2: 261-268. 10.1038/85330.CrossRefPubMed
17.
go back to reference Lin SC, Yen JH, Tsai JJ, Tsai WC, Ou TT, Liu HW, Chen CJ: Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum. 2004, 50: 770-775. 10.1002/art.20040.CrossRefPubMed Lin SC, Yen JH, Tsai JJ, Tsai WC, Ou TT, Liu HW, Chen CJ: Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum. 2004, 50: 770-775. 10.1002/art.20040.CrossRefPubMed
18.
go back to reference Dong H, Zhu K, Tamada K, Chen L: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999, 5: 1365-1369. 10.1038/70932.CrossRefPubMed Dong H, Zhu K, Tamada K, Chen L: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 1999, 5: 1365-1369. 10.1038/70932.CrossRefPubMed
19.
go back to reference Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM, Tsuchiya H: B7DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med. 2001, 193: 839-846. 10.1084/jem.193.7.839.PubMedCentralCrossRefPubMed Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM, Tsuchiya H: B7DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med. 2001, 193: 839-846. 10.1084/jem.193.7.839.PubMedCentralCrossRefPubMed
20.
go back to reference Rietz C, Chen L: New b7 family members with positive and negative costimulatory function. Am J Transplant. 2004, 4: 8-14. 10.1046/j.1600-6143.2003.00303.x.CrossRefPubMed Rietz C, Chen L: New b7 family members with positive and negative costimulatory function. Am J Transplant. 2004, 4: 8-14. 10.1046/j.1600-6143.2003.00303.x.CrossRefPubMed
21.
go back to reference Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T: Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol. 1996, 8: 765-772.CrossRefPubMed Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T: Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol. 1996, 8: 765-772.CrossRefPubMed
22.
go back to reference Vibhakar R, Juan G, Traganos F, Darzynkiewicz Z, Finger LR: Activation-induced expression of human programmed death-1 gene in T-lymphocytes. Exp Cell Res. 1997, 232: 25-28. 10.1006/excr.1997.3493.CrossRefPubMed Vibhakar R, Juan G, Traganos F, Darzynkiewicz Z, Finger LR: Activation-induced expression of human programmed death-1 gene in T-lymphocytes. Exp Cell Res. 1997, 232: 25-28. 10.1006/excr.1997.3493.CrossRefPubMed
23.
go back to reference Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, et al: Expression of programmed death 1 ligands by murine T cells and APC. J Immunol. 2002, 169: 5538-5545.CrossRefPubMed Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, et al: Expression of programmed death 1 ligands by murine T cells and APC. J Immunol. 2002, 169: 5538-5545.CrossRefPubMed
24.
go back to reference Nishimura H, Nose M, Hiai H, Minato N, Honjo T: Development of lupus-like autoimmune disease by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999, 11: 141-151. 10.1016/S1074-7613(00)80089-8.CrossRefPubMed Nishimura H, Nose M, Hiai H, Minato N, Honjo T: Development of lupus-like autoimmune disease by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999, 11: 141-151. 10.1016/S1074-7613(00)80089-8.CrossRefPubMed
25.
go back to reference Bird LA, Peh CA, Kollnberger S, Elliott T, McMichael AJ, Bowness P: Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol. 2003, 33: 748-759. 10.1002/eji.200323678.CrossRefPubMed Bird LA, Peh CA, Kollnberger S, Elliott T, McMichael AJ, Bowness P: Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol. 2003, 33: 748-759. 10.1002/eji.200323678.CrossRefPubMed
26.
go back to reference Boyle LH, Goodall JC, Opat SS, Gaston JS: The recognition of HLA-B27 by human CD4+ T lymphocytes. J Immunol. 2001, 167: 2619-2624.CrossRefPubMed Boyle LH, Goodall JC, Opat SS, Gaston JS: The recognition of HLA-B27 by human CD4+ T lymphocytes. J Immunol. 2001, 167: 2619-2624.CrossRefPubMed
Metadata
Title
Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population
Authors
Sang-Hoon Lee
Yeon-Ah Lee
Doo-Hyun Woo
Ran Song
Eun-Kyung Park
Mi-Hyun Ryu
Young-Hoon Kim
Kyoung-Soo Kim
Seung-Jae Hong
Myung Chul Yoo
Hyung-In Yang
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 6/2007
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2071

Other articles of this Issue 6/2007

Arthritis Research & Therapy 6/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.